<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">32534032</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>06</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>06</Month>
        <Day>17</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1520-6017</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>109</Volume>
            <Issue>9</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Sep</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of pharmaceutical sciences</Title>
          <ISOAbbreviation>J Pharm Sci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Characterization of Polymeric Syringes Used for Intravitreal Injection.</ArticleTitle>
        <Pagination>
          <StartPage>2812</StartPage>
          <EndPage>2818</EndPage>
          <MedlinePgn>2812-2818</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.xphs.2020.06.003</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0022-3549(20)30311-7</ELocationID>
        <Abstract>
          <AbstractText>Intravitreal (IVT) injection is currently the state of the art for drug delivery to the back of the eye. Drug Products (DP) intended for IVT injections usually pose challenges such as a very low injection volume (e.g. 50 μL) and high injection forces. DPs in vials are typically transferred and injected using disposable polymer syringes, which can feature a silicone oil (SO) coating. In our syringe in-use study, we compared dead volume, total SO content and SO layer distributions of three IVT transfer injection syringes. We assessed multiple potential impact factors such as protein concentration, needle gauge, injection speed, surfactant type and the impact of the in-use hold time on sub-visible particle (SvP) formation and injection forces. Pronounced differences were observed between the syringes regarding SvP generation. Siliconized syringes showed higher SvP counts as compared to non-siliconized syringes. In some cases injection forces exceeded 20 N, which caused needles to burst off during injection. The syringes also showed relevant differences in total SO content and dead volume. In conclusion, specific consideration in the selection of an adequate transfer injection syringe are required. This includes extensive testing and characterization under intended and potential in-use conditions and the development of in-use handling procedures.</AbstractText>
          <CopyrightInformation>Copyright © 2020 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Peláez</LastName>
            <ForeName>Sarah S</ForeName>
            <Initials>SS</Initials>
            <AffiliationInfo>
              <Affiliation>Lonza Drug Product Services, Basel, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mahler</LastName>
            <ForeName>Hanns-Christian</ForeName>
            <Initials>HC</Initials>
            <AffiliationInfo>
              <Affiliation>Lonza Drug Product Services, Basel, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Koulov</LastName>
            <ForeName>Atanas</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Lonza Drug Product Services, Basel, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Joerg</LastName>
            <ForeName>Susanne</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Lonza Drug Product Services, Basel, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Matter</LastName>
            <ForeName>Anja</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Lonza Drug Product Services, Basel, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vogt</LastName>
            <ForeName>Martin</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Lonza Drug Product Services, Basel, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chalus</LastName>
            <ForeName>Pascal</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Lonza Drug Product Services, Basel, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zaeh</LastName>
            <ForeName>Maximilian</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Lonza Drug Product Services, Basel, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sediq</LastName>
            <ForeName>Ahmad S</ForeName>
            <Initials>AS</Initials>
            <AffiliationInfo>
              <Affiliation>Lonza Drug Product Services, Basel, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jere</LastName>
            <ForeName>Dhananjay</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Lonza Drug Product Services, Basel, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mathaes</LastName>
            <ForeName>Roman</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Lonza Drug Product Services, Basel, Switzerland. Electronic address: roman.mathaes@lonza.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>06</Month>
          <Day>11</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Pharm Sci</MedlineTA>
        <NlmUniqueID>2985195R</NlmUniqueID>
        <ISSNLinking>0022-3549</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D004364">Pharmaceutical Preparations</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D012827">Silicone Oils</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D058449" MajorTopicYN="N">Intravitreal Injections</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009339" MajorTopicYN="N">Needles</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004364" MajorTopicYN="Y">Pharmaceutical Preparations</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012827" MajorTopicYN="N">Silicone Oils</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013594" MajorTopicYN="Y">Syringes</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">In-use handling</Keyword>
        <Keyword MajorTopicYN="Y">Injection force</Keyword>
        <Keyword MajorTopicYN="Y">Intravitreal injection</Keyword>
        <Keyword MajorTopicYN="Y">Ophthalmic drug product</Keyword>
        <Keyword MajorTopicYN="Y">Polymeric syringe</Keyword>
        <Keyword MajorTopicYN="Y">Silicone oil droplets</Keyword>
        <Keyword MajorTopicYN="Y">Sub-visible particles</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32534032</ArticleId>
        <ArticleId IdType="doi">10.1016/j.xphs.2020.06.003</ArticleId>
        <ArticleId IdType="pii">S0022-3549(20)30311-7</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
